Genetic data will be safeguarded with 23andMe sale, drugmaker vows The Washington PostRegeneron to Buy 23andMe Out of Bankruptcy for $256 Million WSJStruggling DNA testing firm 23andMe to be bought for $256m BBCRegeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale GlobeNewswireRegeneron Pharmaceuticals to buy 23andMe and its data for $256 million CNBC
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
